Research Article
Diagnostic Value of Metagenomic Next-Generation Sequencing for Pneumonia in Immunocompromised Patients
Figure 5
The positivity rate comparison and concordance analysis between mNGS and CTs. (a) The comparisons of the positive rates for mNGS and CTs in immunocompromised patients and immunocompetent patients (). (b) Concordance tests and kappa values were shown between mNGS and CTs for immunocompetent patients and immunocompromised patients.
(a) |
(b) |